"Estramustine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.
| Descriptor ID |
D004961
|
| MeSH Number(s) |
D02.455.526.728.650.275 D04.210.500.365.415.248.320
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Estramustine".
Below are MeSH descriptors whose meaning is more specific than "Estramustine".
This graph shows the total number of publications written about "Estramustine" by people in this website by year, and whether "Estramustine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estramustine" by people in Profiles.
-
A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006. Cancer. 2011 Feb 01; 117(3):526-33.
-
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899. J Transl Med. 2010 Feb 24; 8:20.
-
Chemotherapy for advanced prostate cancer. N Engl J Med. 2005 Jan 13; 352(2):200-1; author reply 200-1.